Pharmaceutical manufacturing, distribution, and RD services in India.
Annual revenue $345,326 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About KanTil Pharmaceuticals

KanTil Pharmaceuticals is a company. KanTil Pharmaceuticals offers products and services including Tablets and Capsules and Injectables and Onco Products.

  • Sectors
    Industrial Goods & Manufacturing
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Social
    Locked
  • Legal Name Kantil Pharmaceuticals Pvt Ltd
  • Jurisdiction Delhi, Delhi, India
Operational Areas
Industrial Goods & Manufacturing → Industrial Materials & Resources Unlock Sub-Sector Unlock Segment
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $345.33 K (USD)
    104.73
    as on Mar 31, 2023
  • Net Profit
    -$113.38 K (USD)
    -9434.03
    as on Mar 31, 2023
  • EBITDA
    -$30.12 K (USD)
    -2563.36
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of KanTil Pharmaceuticals

KanTil Pharmaceuticals offers a comprehensive portfolio of products and services, including Tablets and Capsules and Injectables and Onco Products.

Product name locked
Category locked
Primary

Tablets and capsules are produced for various medicinal uses, covering a range of formulations.

Product name locked
Category locked
Locked

Injectables and oncology products are manufactured through tie-ups with other entities.

Funding Insights of KanTil Pharmaceuticals

Premium access

Detailed funding history for KanTil Pharmaceuticals

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by KanTil Pharmaceuticals

Investments
Premium access

Investment portfolio details for KanTil Pharmaceuticals

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - KanTil Pharmaceuticals

Premium access

Detailed financials for KanTil Pharmaceuticals

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Kantil Pharmaceuticals Comparisons

KanTil Pharmaceuticals Primary company
Description
Pharmaceutical manufacturing, distribution, and R&D services...
Location
-
Founded Year
-
Annual Revenue
$345.33 K (USD)
Net Profit
-$113.38 K (USD)
EBITDA
-$30.12 K (USD)
Employees
Not available
Premium access

Peer comparison for KanTil Pharmaceuticals

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of KanTil Pharmaceuticals

Premium access

Detailed competitors of KanTil Pharmaceuticals

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Kantil Pharmaceuticals

Premium access

Complete news archive for KanTil Pharmaceuticals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about KanTil Pharmaceuticals

Annual revenue of KanTil Pharmaceuticals is $345.33K as on Mar 31, 2023.

KanTil Pharmaceuticals is known for its focus on innovation in the pharmaceutical sector, where a wide array of products such as tablets, capsules, syrups, and creams is manufactured and prepared for export. RD efforts are maintained to develop new formulations in speciality areas, and partnerships with exporters are established to expand reach. Quality services are provided as a one-stop solution for healthcare needs, with ethical practices and customer-oriented approaches being emphasized in operations. Adherence to standards ensures timely delivery of medicines.

KanTil Pharmaceuticals offers Tablets and Capsules and Injectables and Onco Products.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available